MoneyWorks4Me

Kwality Pharmaceuticals informs about disclosure

07 May 2025 Evaluate
Kwality Pharmaceuticals has informed that the company has successfully concluded a regulatory audit for Zimbabwe across its General, Beta-Lactam, Cephalosporin and Oncology units, with no critical observations. This marks yet another milestone in its series of successful audits over the past year.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1759.10
Dr. Reddys Labs. 1230.50
Cipla 1313.70
Lupin 1946.00
Zydus Lifesciences 1139.00
View more..